Individuals with more robust microglial responses to amyloid—such as APOE4 carriers or those in pro-inflammatory states—may experience faster tau spread and more rapid cognitive decline, a pattern supported by several epidemiological studies [81, 82]. This evidence concerns the gene MAPT and Mental deterioration.